BRPI0820290A2 - Processo para preparar um sal de dibenzoil-l-tartarato diastereomericamente puro de um composto, mono-dibenzoil-l-tartarato, e, uso de um dibenzoil-l-tartarato. - Google Patents

Processo para preparar um sal de dibenzoil-l-tartarato diastereomericamente puro de um composto, mono-dibenzoil-l-tartarato, e, uso de um dibenzoil-l-tartarato.

Info

Publication number: BRPI0820290A2
Authority: BR; Brazil
Prior art keywords: dibenzoyl; tartrate; mono; preparing; compound
Prior art date: 2007-11-15

Application number

BRPI0820290-7A

Other languages

English (en)

Inventor

Rhony Aufdenblatten

Martin Hans Bohlin

Laurent Ducry

Mattias Magnusson

Ulrika Lindblad

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-15

Filing date

2008-11-14

Publication date

2015-05-26

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40638952&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0820290(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-11-14 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2015-05-26 Publication of BRPI0820290A2 publication Critical patent/BRPI0820290A2/pt

Links

229940095064 tartrate Drugs 0.000 title 2
150000001875 compounds Chemical class 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0820290-7A 2007-11-15 2008-11-14 Processo para preparar um sal de dibenzoil-l-tartarato diastereomericamente puro de um composto, mono-dibenzoil-l-tartarato, e, uso de um dibenzoil-l-tartarato. BRPI0820290A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US98812107P	2007-11-15	2007-11-15
PCT/SE2008/051305 WO2009064249A1 (en)	2007-11-15	2008-11-14	A process for the preparation of (3ar,4s, 6r, 6as)-6-amino-2, 2- dimethyltetrahydro-3ah-cyclopenta[d] [1,3] dioxol-4-ol dibenzoyl-l-tartrate and to products of said process

Publications (1)

Publication Number	Publication Date
BRPI0820290A2 true BRPI0820290A2 (pt)	2015-05-26

Family

ID=40638952

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0820290-7A BRPI0820290A2 (pt)	2007-11-15	2008-11-14	Processo para preparar um sal de dibenzoil-l-tartarato diastereomericamente puro de um composto, mono-dibenzoil-l-tartarato, e, uso de um dibenzoil-l-tartarato.

Country Status (17)

Country	Link
US (2)	US7816545B2 (pt)
EP (1)	EP2220064B1 (pt)
JP (1)	JP5562864B2 (pt)
KR (1)	KR101570888B1 (pt)
CN (1)	CN101861310A (pt)
AR (1)	AR069325A1 (pt)
AU (1)	AU2008321575B2 (pt)
BR (1)	BRPI0820290A2 (pt)
CA (1)	CA2704001A1 (pt)
CL (1)	CL2008003396A1 (pt)
ES (1)	ES2567450T3 (pt)
IL (1)	IL205361A0 (pt)
MX (1)	MX2010005406A (pt)
MY (1)	MY155721A (pt)
RU (1)	RU2477277C2 (pt)
TW (1)	TWI496776B (pt)
WO (1)	WO2009064249A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI496776B (zh) *	2007-11-15	2015-08-21	Astrazeneca Ab	製備(3aR,4S,6R,6aS)-6-胺基-2,2-二甲基四氫-3aH-環戊并[d][1,3]二氧雜環戊烯-4-醇之純非對映異構性之二苯甲醯-L-酒石酸鹽之方法
WO2012063126A2 (en)	2010-11-09	2012-05-18	Actavis Group Ptc Ehf	Improved processes for preparing pure (3ar,4s,6r,6as)-6-amino-2,2-dimethyltetrahdro-3ah-cyclopenta[d] [1,3]-dioxol-4-ol and its key starting material
US20130317220A1 (en)	2010-12-20	2013-11-28	Actavis Group Ptc Ehf	NOVEL PROCESSES FOR PREPARING TRIAZOLO[4, 5-d]PYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF
CZ303364B6 (cs) *	2011-04-19	2012-08-15	Zentiva, K.S.	Opticky aktivní soli (3aR,4S,6R,6aS)-6-amino-2,2-dimethyltetrahydro-3aH-cyklopenta-[d][1,3]dioxol-4-olu a zpusob jejich prípravy
CN103534245B (zh) *	2011-05-13	2015-08-19	阿斯利康(瑞典)有限公司	[(3aS,4R,6S,6aR)-6-羟基-2,2-二甲基四氢-3aH-环戊二烯并[d][1,3]二氧戊环-4-基]氨基甲酸苄酯的制备方法和该方法中的中间体
WO2012172426A1 (en)	2011-06-15	2012-12-20	Actavis Group Ptc Ehf	Improved process for preparing cyclopentylamine derivatives and intermediates thereof
CN104513221A (zh) *	2013-09-26	2015-04-15	上海科胜药物研发有限公司	一种制备光学活性的替卡格雷中间体的方法
WO2015162630A1 (en)	2014-04-25	2015-10-29	Anlon Chemical Research Organization	Novel processes for preparing triazolo [4,5-d]- pyrimidines, including ticagrelor, vianew intermediates and new route of synthesis.
CN106478587A (zh) *	2016-08-30	2017-03-08	苏州天马精细化学品股份有限公司	一种替格瑞洛中间体的合成方法
CN117551071A (zh) *	2023-10-13	2024-02-13	重庆普佑生物医药有限公司	替卡格雷中间体及其制备方法和应用该中间体的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9702772D0 (sv) *	1997-07-22	1997-07-22	Astra Pharma Prod	Novel compounds
SE9702773D0 (sv) *	1997-07-22	1997-07-22	Astra Pharma Prod	Novel compounds
TWI229674B (en) *	1998-12-04	2005-03-21	Astra Pharma Prod	Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013407D0 (en) *	2000-06-02	2000-07-26	Astrazeneca Ab	Forms of a chemical compound
GB0013488D0 (en) *	2000-06-02	2000-07-26	Astrazeneca Ab	Chemical compound
IT1318650B1 (it) *	2000-07-28	2003-08-27	Dompe Spa	1,3-diossolani ad attivita' antitosse.
TWI496776B (zh) *	2007-11-15	2015-08-21	Astrazeneca Ab	製備(3aR,4S,6R,6aS)-6-胺基-2,2-二甲基四氫-3aH-環戊并[d][1,3]二氧雜環戊烯-4-醇之純非對映異構性之二苯甲醯-L-酒石酸鹽之方法

2008
- 2008-11-13 TW TW097143957A patent/TWI496776B/zh not_active IP Right Cessation
- 2008-11-14 RU RU2010120529/04A patent/RU2477277C2/ru not_active IP Right Cessation
- 2008-11-14 AR ARP080104975A patent/AR069325A1/es unknown
- 2008-11-14 CA CA2704001A patent/CA2704001A1/en not_active Abandoned
- 2008-11-14 CN CN200880116249A patent/CN101861310A/zh active Pending
- 2008-11-14 BR BRPI0820290-7A patent/BRPI0820290A2/pt not_active IP Right Cessation
- 2008-11-14 ES ES08849065.1T patent/ES2567450T3/es active Active
- 2008-11-14 CL CL2008003396A patent/CL2008003396A1/es unknown
- 2008-11-14 WO PCT/SE2008/051305 patent/WO2009064249A1/en not_active Ceased
- 2008-11-14 KR KR1020107013081A patent/KR101570888B1/ko not_active Expired - Fee Related
- 2008-11-14 EP EP08849065.1A patent/EP2220064B1/en active Active
- 2008-11-14 JP JP2010533996A patent/JP5562864B2/ja active Active
- 2008-11-14 AU AU2008321575A patent/AU2008321575B2/en not_active Ceased
- 2008-11-14 US US12/270,999 patent/US7816545B2/en active Active
- 2008-11-14 MY MYPI2010002502A patent/MY155721A/en unknown
- 2008-11-14 MX MX2010005406A patent/MX2010005406A/es active IP Right Grant
2010
- 2010-04-26 IL IL205361A patent/IL205361A0/en not_active IP Right Cessation
- 2010-09-17 US US12/885,416 patent/US20110009647A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2008321575B2 (en)	2012-07-05
ES2567450T3 (es)	2016-04-22
KR20100088696A (ko)	2010-08-10
US20110009647A1 (en)	2011-01-13
IL205361A0 (en)	2010-12-30
AU2008321575A1 (en)	2009-05-22
MY155721A (en)	2015-11-30
CA2704001A1 (en)	2009-05-22
EP2220064A1 (en)	2010-08-25
EP2220064A4 (en)	2011-09-07
AR069325A1 (es)	2010-01-13
US20090182157A1 (en)	2009-07-16
MX2010005406A (es)	2010-08-11
JP2011503177A (ja)	2011-01-27
WO2009064249A1 (en)	2009-05-22
RU2477277C2 (ru)	2013-03-10
CN101861310A (zh)	2010-10-13
EP2220064B1 (en)	2016-02-10
TW200936574A (en)	2009-09-01
TWI496776B (zh)	2015-08-21
RU2010120529A (ru)	2011-12-20
KR101570888B1 (ko)	2015-11-20
US7816545B2 (en)	2010-10-19
CL2008003396A1 (es)	2010-02-19
JP5562864B2 (ja)	2014-07-30

Similar Documents

Publication	Publication Date	Title
BRPI0820290A2 (pt)	2015-05-26	Processo para preparar um sal de dibenzoil-l-tartarato diastereomericamente puro de um composto, mono-dibenzoil-l-tartarato, e, uso de um dibenzoil-l-tartarato.
BRPI0918038A2 (pt)	2015-08-04	Processos para preparar um composto e um sal, e, composto
BRPI0919018A2 (pt)	2015-12-08	sal farmaceuticamente aceitável, uso de sal, e, processo para a preparação de sal
BRPI0910734A2 (pt)	2015-09-29	composto, composição farmacêutica, e, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo.
BRPI0816331A2 (pt)	2015-04-14	Composto, uso de um composto, composição farmacêutica, e, processo para preparar um composto.
BRPI0908252A2 (pt)	2015-07-21	Processo para preparar um composto, e, uso de um composto
BRPI1006162A2 (pt)	2019-09-24	"composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto".
BRPI0812054A2 (pt)	2014-11-18	Processo para preparar compostos, e, compostos.
BRPI1006534A2 (pt)	2016-08-02	sal do composto 1, processo para preparar um sal do composto 1, e processo para preparar um sal misto do composto 1
BRPI0717751A2 (pt)	2013-10-22	Processo para a fabricação de um composto, composto, e, sal de um composto.
BRPI1014547A2 (pt)	2016-04-05	composto, e, processo para preparar um composto.
BRPI1014691A2 (pt)	2015-08-25	Composto, e, processo para a preparação de um composto.
BRPI0908738A2 (pt)	2017-06-13	composto, medicamento, uso de um composto, e, processo para preparar os compostos
BRPI0911898A2 (pt)	2015-10-13	processo para preparar compostos, e, composto.
BR112012029226A2 (pt)	2015-10-20	processo para a preparação de um composto quiral, composto quiral cristalino, sal de hcl do composto quiral cristalino, composto quiral e uso do composto
BRPI0910785A2 (pt)	2018-01-09	sal de eritromicina hidratado, composição farmacêutica, processo para preparar um sal de eritromicina hidratado e uso de sal de eritromicina hidratado
BRPI1011888A2 (pt)	2016-04-12	processo para preparar um composto, e, composição.
BRPI0911897A2 (pt)	2015-07-28	Processo para a preparação de compostos, e, composto
BRPI0813438A2 (pt)	2014-12-23	Processo para preparar um composto, uso de um composto, e, composto.
BRPI0817305A2 (pt)	2015-03-17	Sal de amina orgânica, e, processo para produzir um sal de amina orgânica.
BRPI0922836A2 (pt)	2016-10-18	processo para a preparação de um sal de succinato monovalente
BR112012016201A2 (pt)	2017-12-19	''composto, processo para a preparação de um composto, composição farmacêutica e uso de um composto''
BRPI0917147A2 (pt)	2015-11-17	composto ou sal deste, uso de um composto ou sal deste, e, processo para fabricar um composto.
BRPI0912163A2 (pt)	2015-08-11	Composto químico, processo para a produção de um composto, compsição química, e, uso de um composto químico.
BRPI0820289A2 (pt)	2015-05-26	Processo para preparar ácido cianídrico, e, uso de um microevaporador.

Legal Events

Date	Code	Title	Description
2017-09-12	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2018-01-02	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]